Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,446 | 377 | 53.6% |
| Travel and Lodging | $7,909 | 13 | 44.9% |
| Education | $267.33 | 21 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $8,361 | 35 | $0 (2020) |
| Boston Scientific Corporation | $1,758 | 20 | $0 (2024) |
| Edwards Lifesciences Corporation | $770.50 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $689.44 | 27 | $0 (2022) |
| Medtronic, Inc. | $630.82 | 9 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $562.68 | 40 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $560.84 | 29 | $0 (2024) |
| PFIZER INC. | $509.14 | 36 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $457.23 | 32 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $375.98 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,084 | 41 | Boston Scientific Corporation ($1,281) |
| 2023 | $1,119 | 38 | Edwards Lifesciences Corporation ($372.54) |
| 2022 | $853.77 | 23 | Medtronic, Inc. ($202.52) |
| 2021 | $1,047 | 25 | Medtronic, Inc. ($385.84) |
| 2020 | $2,754 | 26 | Medtronic Vascular, Inc. ($2,378) |
| 2019 | $1,479 | 78 | Boehringer Ingelheim Pharmaceuticals, Inc. ($255.47) |
| 2018 | $6,565 | 89 | Medtronic Vascular, Inc. ($5,524) |
| 2017 | $1,721 | 91 | Medtronic Vascular, Inc. ($307.65) |
All Payment Transactions
411 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: WATCHMAN_IC | ||||||
| 12/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Obesity | ||||||
| 11/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Genetic Disease | ||||||
| 11/02/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $214.10 | General |
| Category: WATCHMAN_IC | ||||||
| 11/01/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Travel and Lodging | In-kind items and services | $560.10 | General |
| Category: WATCHMAN_IC | ||||||
| 11/01/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Travel and Lodging | In-kind items and services | $292.08 | General |
| Category: WATCHMAN_IC | ||||||
| 11/01/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $124.65 | General |
| Category: WATCHMAN_IC | ||||||
| 10/14/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $26.22 | General |
| 09/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.88 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.83 | General |
| Category: Cardiovascular | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Cardiology | ||||||
| 07/22/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: WATCHMAN_IC | ||||||
| 07/15/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.49 | General |
| 07/09/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $35.03 | General |
| Category: Transcatheter Heart Valves | ||||||
| 07/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Obesity | ||||||
| 06/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.27 | General |
| Category: Cardiovascular | ||||||
| 06/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,356 | 5,873 | $1.3M | $299,716 |
| 2022 | 27 | 2,658 | 9,439 | $1.4M | $319,017 |
| 2021 | 26 | 2,519 | 8,221 | $1.3M | $303,075 |
| 2020 | 28 | 2,666 | 10,099 | $1.3M | $300,585 |
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 653 | 1,113 | $372,855 | $98,526 | 26.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 136 | 139 | $212,948 | $47,072 | 22.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 266 | 279 | $198,369 | $36,390 | 18.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 136 | 278 | $52,820 | $20,531 | 38.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 116 | 140 | $63,280 | $18,711 | 29.6% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 23 | 23 | $85,307 | $12,878 | 15.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $48,735 | $10,073 | 20.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 49 | 49 | $39,102 | $9,988 | 25.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 50 | 200 | $16,160 | $8,800 | 54.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 64 | $16,256 | $5,775 | 35.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 118 | 118 | $26,605 | $5,696 | 21.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 13 | 13 | $19,669 | $5,666 | 28.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 106 | 107 | $25,466 | $5,168 | 20.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 27 | $13,338 | $3,644 | 27.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 11 | 17 | $9,282 | $2,815 | 30.3% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $10,788 | $2,181 | 20.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 126 | 134 | $6,817 | $1,277 | 18.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 174 | 190 | $8,540 | $1,059 | 12.4% |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 2023 | 29 | 2,700 | $21,600 | $1,055 | 4.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 44 | 46 | $4,600 | $845.48 | 18.4% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 25 | 25 | $2,500 | $486.48 | 19.5% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 44 | 46 | $2,070 | $402.48 | 19.4% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 17 | 17 | $1,428 | $245.65 | 17.2% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 17 | 17 | $1,428 | $225.88 | 15.8% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 24 | 24 | $1,080 | $206.31 | 19.1% |
About Dr. Maziar Azadpour, M.D
Dr. Maziar Azadpour, M.D is a Cardiovascular Disease healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730131855.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maziar Azadpour, M.D has received a total of $17,622 in payments from pharmaceutical and medical device companies, with $2,084 received in 2024. These payments were reported across 411 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($9,446).
As a Medicare-enrolled provider, Azadpour has provided services to 10,199 Medicare beneficiaries, totaling 33,632 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Salem, OR
- Active Since 05/17/2006
- Last Updated 01/24/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1730131855
Products in Payments
- Resolute (Device) $8,291
- WATCHMAN Access System (Device) $1,442
- ELIQUIS (Drug) $634.13
- XARELTO (Drug) $562.68
- JARDIANCE (Drug) $396.15
- ENTRESTO (Drug) $380.41
- CoreValve Evolut (Device) $315.60
- BRILINTA (Drug) $299.98
- PRADAXA (Drug) $274.27
- FARXIGA (Drug) $251.86
- Corlanor (Drug) $229.99
- COREVALVE EVOLUT R (Device) $229.16
- LifeVest (Device) $195.41
- PRALUENT (Drug) $154.55
- BYSTOLIC (Drug) $148.35
- WATCHMAN (Device) $134.43
- PRALUENT ALIROCUMAB INJECTION (Biological) $131.14
- CAMZYOS (Drug) $125.10
- General - Vascular Access (Device) $125.00
- PERCLOSE PROGLIDE (Device) $121.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Salem
Kevin Thompson, Do, DO
Cardiovascular Disease — Payments: $101,034
Ashit Patel, M.d, M.D
Cardiovascular Disease — Payments: $54,451
Dr. Sandeep Saha, M.d, M.D
Cardiovascular Disease — Payments: $43,942
Dr. Andrew Maiolo, Md, MD
Cardiovascular Disease — Payments: $19,968
Barath Krishnamurthy, Md, MD
Cardiovascular Disease — Payments: $13,695
Deborah Hughes, M.d, M.D
Cardiovascular Disease — Payments: $10,535